Boardroom Alpha
Start trial
8-K primary document
EYPT · Current Report (Form 8-K) · Filed December 8, 2025

Eyepoint Inc — 8-K exhibit

d60563dex31.htm
Eyepoint Inc on Boardroom Alpha
EX-3.1

Exhibit 3.1

CERTIFICATE OF AMENDMENT TO THE

CERTIFICATE OF INCORPORATION

OF

EYEPOINT PHARMACEUTICALS, INC.

EyePoint Pharmaceuticals, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), for the purpose of amending its Certificate of Incorporation, as amended (the “Certificate of Incorporation”), in accordance with the DGCL, does hereby make and execute this Certificate of Amendment to the Certificate of Incorporation, and does hereby certify that:

 

1.

That the Board of Directors of the Corporation, by the unanimous written consent of its members, adopted resolutions setting forth the proposed amendment to the Certificate of Incorporation of the Corporation, declaring said amendment to be advisable and in the best interests of the Corporation and its stockholders in accordance with the provisions of Section 242 of the DGCL. The resolution setting forth the proposed amendment is as follows:

RESOLVED, that the first section of the Certificate of Incorporation of the Corporation be amended in its entirety as follows:

“The name of this corporation is EyePoint, Inc.”

 

2.

The Certificate of Amendment to the Certificate of Incorporation has been duly adopted and approved by the Board of Directors in accordance with the provisions of Section 242 of the DGCL

 

3.

That except as amended hereby, the provisions of the Certificate of Incorporation, shall remain in full force and effect.

 

4.

This Certificate of Amendment to the Certificate of Incorporation shall be effective as of December 8, 2025.

[Remainder of Page Intentionally Blank]

IN WITNESS WHEREOF, I have signed this Certificate of Amendment this 8th day of December, 2025.

 

EYEPOINT PHARMACEUTICALS, INC.
By:  

/s/ Ron Honig

Name:   Ron Honig
Title:   Chief Legal Officer

[Signature Page to Certificate of Amendment]

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer